NCT03916796

Brief Summary

This is a pilot study with a feasibility lead-in evaluating the use of multimodal cancer rehabilitation in patients planning to undergo radiotherapy and surgical resection for extremity or superficial trunk soft tissue sarcoma (STS). At enrollment, patients will be assigned to either a pre-operative radiation or post-operative radiation cohort.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

October 31, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2022

Completed
Last Updated

April 12, 2022

Status Verified

April 1, 2022

Enrollment Period

1.8 years

First QC Date

April 10, 2019

Last Update Submit

April 4, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of prescribed dietary and physical therapy visits completed during the cancer rehabilitation protocol

    * This will be quantified as the proportion of prescribed visits within the prehabilitation protocol that are attended by the patient. If a patient participates in any portion of a prescribed visit, it will be counted as attended. * Physical therapy visits are optional from 6 months-24 months

    Through 3 month follow-up

Secondary Outcomes (10)

  • Rate of acute treatment-related grade 2 or higher toxicity attributed to the therapy

    From baseline through 24 month follow-up

  • Quality of life as measured by the PROMIS Global total score

    Change from baseline through 24 month follow-up

  • Quality of life as measured by the TESS

    Change from baseline through 24 month follow-up

  • Patient cardiovascular capacity as measured by the 6-minute walk test

    Change from baseline through 3 month follow-up

  • Patient general physical health status as measured by 30-second sit to stand test

    Change from baseline through 3 month follow-up

  • +5 more secondary outcomes

Study Arms (2)

Pre-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological Counsel

EXPERIMENTAL

* Patients must be treated using daily image-guided radiotherapy * Dietary counseling at baseline * Exercise intervention throughout cancer rehabilitation protocol * Psychological screening with counselling services as needed - nurse will administer the NCCN distress thermometer and refer the patient to applicable psychological counselling

Other: ExerciseOther: Enhanced Recovery after surgeryOther: Psychological screening with counselling services as neededOther: Dietary Counseling Services

Post-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological Counsel

EXPERIMENTAL

* Patients must be treated using daily image-guided radiotherapy * Dietary counseling at baseline * Exercise intervention throughout cancer rehabilitation protocol * Psychological screening with counselling services as needed - nurse will administer the NCCN distress thermometer and refer the patient to applicable psychological counselling

Other: ExerciseOther: Enhanced Recovery after surgeryOther: Psychological screening with counselling services as neededOther: Dietary Counseling Services

Interventions

-The exercise part will consist of an evaluation and treatment as prescribed by a physical therapist including aerobic \& dynamic stretching warm-up, strength training, balance training, and flexibility training. Will also include a home exercise program (HEP). Physical therapists will have specialized training in cancer rehabilitation obtained through the ReVital certification process.

Post-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological CounselPre-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological Counsel

-The protocols include instructions for patient care from the time of pre-surgical admission to discharge, including directives regarding diet, labs, IV fluids, pain management, prophylactic medications, management of indwelling catheters and drains, and activity.

Also known as: ERAS
Post-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological CounselPre-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological Counsel

-The psychological screening will be completed by the Radiation Oncology nurse at the consult visit

Post-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological CounselPre-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological Counsel

-Patients will have a baseline nutrition counseling visit with a Registered Dietician. This may include a nutrition assessment and nutrition counseling to set priorities, establish goals, and create an individualized plan

Post-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological CounselPre-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological Counsel

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically or cytologically confirmed soft tissue sarcoma of the extremity, or superficial trunk (abdomen or chest)
  • Planning to receive radiotherapy and surgical resection
  • At least 16 years of age.
  • ECOG performance status ≤ 3
  • Able to complete the cancer rehabilitation protocol safely, as determined by a treating physician.
  • Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).

You may not qualify if:

  • Patients deemed ineligible for curative therapy by the treating medical oncologist, radiation oncologist, or surgeon.
  • Patients with deep retroperitoneal or abdominal STS
  • Patients who have received prior radiotherapy and, based on the treating radiation oncologist's opinion, may not safely be treated with protocol neoadjuvant radiotherapy.
  • Currently receiving any investigational agents.
  • Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, or cardiac arrhythmia.
  • Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test prior to starting radiotherapy.
  • HIV-positive patients whose CD4+ T-cell count is \< 350 cells/mcL.
  • Receiving concurrent chemoradiation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

MeSH Terms

Conditions

Sarcoma

Interventions

ExerciseEnhanced Recovery After SurgeryHealth Services Needs and Demand

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaPerioperative CareSurgical Procedures, OperativeHealth Services ResearchHealth PlanningHealth Care Economics and OrganizationsDelivery of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • Matthew Spraker, M.D., Ph.D.

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2019

First Posted

April 16, 2019

Study Start

October 31, 2019

Primary Completion

August 17, 2021

Study Completion

March 18, 2022

Last Updated

April 12, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations